Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Helena Laboratories

Helena Laboratories is a clinical laboratory instrument and reagent manufacturer with a product range comprising elec... read more Featured Products: More products

Download Mobile App





Helena Laboratories Showcases Electrophoresis and Hemostasis Solutions

By LabMedica International staff writers
Posted on 30 Jul 2026

Helena Laboratories (Beaumont, TX, USA) is showcasing clinical laboratory technologies at ADLM 2026 in Anaheim, California. More...

At booth 1515, the company is highlighting capillary and gel electrophoresis systems, point-of-care hemostasis solutions, and laboratory plastics from Labcon.

A central feature of the exhibit is the new V8 UltraCE, a next-generation capillary electrophoresis analyzer designed to provide faster, more connected, and flexible workflows. The system incorporates accelerated capillary technology, connectivity with laboratory automation tracks, and an integrated workflow that enables laboratories to reflex selected samples to gel electrophoresis.

The V8 UltraCE uses a precision horseshoe-shaped capillary array with active cooling to help prevent sample degradation. Its Nanocell Technology combines shorter, narrower capillaries with enhanced signal detection to improve throughput and analytical precision, while integrated cap-piercing and needle-washing features help reduce manual handling and cross-contamination. The system is currently under FDA premarket review and is not available for sale in the United States.

Helena is also presenting the SPIFE Nexus, a fully automated gel electrophoresis platform for serum protein, immunofixation, hemoglobin, and other assays. After samples and supplies are loaded, the system automates sample application, electrophoresis, staining, washing, drying, scanning, and reporting, reducing technologist involvement during routine testing.

The SPIFE Nexus supports up to 15 immunofixation profiles and incorporates automated antisera dispensing with a temperature-controlled reagent compartment. Assay-specific QR codes provide automated pre-run checks, while QuickScan Touch Plus software connects current gel and capillary electrophoresis findings with historical patient results for remote interpretation and integrated reporting.

For point-of-care hemostasis, Helena is featuring Plateletworks for measuring functional platelet counts and platelet aggregation or inhibition using standard agonists. The company is also highlighting Actalyke activated clotting time analyzers and MAX-ACT tubes for monitoring heparin dosing during procedures requiring anticoagulation.

Completing the showcase are disposable laboratory plastics from Labcon. Together, Helena’s ADLM 2026 offerings demonstrate technologies designed to increase laboratory automation, support reliable electrophoresis and hemostasis testing, and improve efficiency across routine clinical workflows.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automatic CLIA Analyzer
Shine i6000
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Dr. Maria “Ken” Figueroa is investigating how epigenetics can inform treatment paths for cancer patients. (Image Credit: Sylvester Comprehensive Cancer Center)

DNA Methylation May Predict Treatment Response in Myelodysplastic Syndromes

Myelodysplastic syndromes (MDS) are disorders in which the bone marrow does not produce healthy blood cells normally. Treatment selection can be challenging because clinicians cannot reliably predict which... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: Melioidosis is a serious, sometimes fatal infection caused by Burkholderia pseudomallei, a bacterium found in tropical and subtropical soil and surface water. (Image Credit: Adobe Stock)

Antibody Testing Informs Melioidosis Diagnosis and Surveillance in Emerging Regions

Melioidosis is a serious and sometimes fatal infection caused by the soil- and water-dwelling bacterium Burkholderia pseudomallei. People and animals can contract the disease through exposure to contaminated... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: Siemens Healthineers has begun carving out its in vitro diagnostics business as a standalone company named Olyrian Diagnostics (Photo courtesy of Siemens Healthineers)

Siemens Healthineers Begins Transition Toward Standalone Olyrian Diagnostics Business

Siemens Healthineers has begun carving out its in vitro diagnostics business, which will operate as Olyrian Diagnostics. The new name will be introduced in stages as the business prepares to become a standalone... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.